Search details
1.
Impact of dose-escalation schemes and drug discontinuation on weight loss outcomes with liraglutide 3.0 mg: A model-based approach.
Diabetes Obes Metab
; 22(6): 969-977, 2020 06.
Article
in English
| MEDLINE | ID: mdl-32009288
2.
Prolonged half-life and preserved enzymatic properties of factor IX selectively PEGylated on native N-glycans in the activation peptide.
Blood
; 118(8): 2333-41, 2011 Aug 25.
Article
in English
| MEDLINE | ID: mdl-21700771
3.
Pharmacokinetics and pharmacodynamics of rFVIIa and new improved bypassing agents for the treatment of haemophilia.
Haemophilia
; 18 Suppl 5: 6-10, 2012 Jul.
Article
in English
| MEDLINE | ID: mdl-22757678
4.
Blockade of NKG2D ameliorates disease in mice with collagen-induced arthritis: a potential pathogenic role in chronic inflammatory arthritis.
Arthritis Rheum
; 63(9): 2617-29, 2011 Sep.
Article
in English
| MEDLINE | ID: mdl-21618462
5.
Dose/exposure-response modeling in dose titration trials: Overcoming the titration paradox.
CPT Pharmacometrics Syst Pharmacol
; 11(12): 1592-1603, 2022 12.
Article
in English
| MEDLINE | ID: mdl-36125910
6.
Intravascular inhibition of factor VIIa and the analogue NN1731 by antithrombin.
Br J Haematol
; 152(1): 99-107, 2011 Jan.
Article
in English
| MEDLINE | ID: mdl-21083658
7.
Optimal Monitoring of Weekly IGF-I Levels During Growth Hormone Therapy With Once-Weekly Somapacitan.
J Clin Endocrinol Metab
; 106(2): 567-576, 2021 01 23.
Article
in English
| MEDLINE | ID: mdl-33313798
8.
Population Pharmacokinetics and Pharmacodynamics of Once-Daily Growth Hormone Norditropin® in Children and Adults.
Clin Pharmacokinet
; 60(9): 1217-1226, 2021 09.
Article
in English
| MEDLINE | ID: mdl-33864240
9.
Identification and preclinical development of an anti-proteolytic uPA antibody for rheumatoid arthritis.
J Mol Med (Berl)
; 98(4): 585-593, 2020 04.
Article
in English
| MEDLINE | ID: mdl-32108909
10.
Pharmacokinetics and Pharmacodynamics of Once-Weekly Somapacitan in Children and Adults: Supporting Dosing Rationales with a Model-Based Analysis of Three Phase I Trials.
Clin Pharmacokinet
; 58(1): 63-75, 2019 01.
Article
in English
| MEDLINE | ID: mdl-29671202
11.
Response to "mixed-effects models and the drug titration paradox".
CPT Pharmacometrics Syst Pharmacol
; 12(4): 430-431, 2023 Apr.
Article
in English
| MEDLINE | ID: mdl-36825308
12.
Prediction of human pharmacokinetics of activated recombinant factor VII and B-domain truncated factor VIII from animal population pharmacokinetic models of haemophilia.
Eur J Pharm Sci
; 115: 196-203, 2018 Mar 30.
Article
in English
| MEDLINE | ID: mdl-29369801
13.
Pharmacokinetics of desmopressin administrated as an oral lyophilisate dosage form in children with primary nocturnal enuresis and healthy adults.
J Clin Pharmacol
; 46(10): 1204-11, 2006 Oct.
Article
in English
| MEDLINE | ID: mdl-16988210
14.
The elimination rates of intact GIP as well as its primary metabolite, GIP 3-42, are similar in type 2 diabetic patients and healthy subjects.
Regul Pept
; 137(3): 168-72, 2006 Dec 10.
Article
in English
| MEDLINE | ID: mdl-16934887
15.
The kidneys play a central role in the clearance of rhGH in rats.
Eur J Pharm Sci
; 86: 29-33, 2016 Apr 30.
Article
in English
| MEDLINE | ID: mdl-26946443
16.
Bedtime administration of NN2211, a long-acting GLP-1 derivative, substantially reduces fasting and postprandial glycemia in type 2 diabetes.
Diabetes
; 51(2): 424-9, 2002 Feb.
Article
in English
| MEDLINE | ID: mdl-11812750
17.
Pharmacokinetics, pharmacodynamics, safety, and tolerability of a single-dose of NN2211, a long-acting glucagon-like peptide 1 derivative, in healthy male subjects.
Diabetes Care
; 25(8): 1398-404, 2002 Aug.
Article
in English
| MEDLINE | ID: mdl-12145241
18.
Pharmacokinetics and pharmacodynamics of a new formulation of recombinant human growth hormone administered by ZomaJet 2 Vision, a new needle-free device, compared to subcutaneous administration using a conventional syringe.
J Clin Pharmacol
; 42(11): 1262-8, 2002 Nov.
Article
in English
| MEDLINE | ID: mdl-12412826
19.
Pharmacodynamics of NN2211, a novel long acting GLP-1 derivative.
Eur J Pharm Sci
; 19(2-3): 141-50, 2003 Jun.
Article
in English
| MEDLINE | ID: mdl-12791417
20.
The dosing solution influence on the pharmacokinetics of degarelix, a new GnRH antagonist, after s.c. administration to beagle dogs.
Eur J Pharm Sci
; 20(3): 335-40, 2003 Nov.
Article
in English
| MEDLINE | ID: mdl-14592699